Transfection Technologies Market Size to Hit US$ 1,747.7 Million by 2028 | With a 8.5% CAGR

The latest report by IMARC Group, titled "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The global transfection technologies market size reached US$ 1,080.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,747.7 Million by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.

Transfection technology is a procedure that involves the artificial introduction of nucleic acid, such as DNA, RNA, and oligonucleotides, into cells. It is performed using several physical, chemical, and biological methods, which enable the modification of specific cellular properties. Some commonly used techniques include co transfection, electroporation, cationic lipid transfection, and in-vivo transfection. At present, transfection technologies find extensive applications in genomic studies, such as gene expression, screening, RNA interference, and Vivo research, and for the bioproduction of vaccines and proteins across the globe.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/transfection-technologies-market/requestsample

Transfection Technologies Market Trends and Drivers:

The global transfection technologies market is primarily driven by the rising prevalence of cancer and chronic lifestyle diseases. Moreover, the surging adoption of reagent-based methods is positively influencing market growth. Additionally, the increasing popularity of instrument-based methods, such as biolistic technology, microinjection, and laserfection, has catalyzed market growth. Furthermore, numerous technological advancements in cell research and therapeutic discovery, particularly in gene transfer research conducted under in-vivo conditions to develop new therapeutic drugs and applications, are contributing to the market growth. Other factors, including extensive research and development (R&D) activities, the introduction of novel techniques for transient transfection with improved stability and minimal off-target effects, and heavy investments from government and private organizations to develop large-scale transfection facilities, are also anticipated to propel market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

Reagent
Instrument
Others

Breakup by Application:

Therapeutic Delivery
Bio-Medical Research
Protein Production
Others

Breakup by Transfection Method:

Lipofection
Eletroporation
Nucleofection
Cotransfection
Cationic Lipid Transfection
In-Vivo Transfection
Others

Breakup by Technology:

Physical Transfection
Biochemical Based Transfection
Viral-Vector Based Transfection

Breakup by End-User:

Research Centers and Academic Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

Breakup by Region:

North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa

Competitors Landscape with Key Players:

Agilent Technologies Inc.
Bio-RAD Laboratories Inc.
Lonza Group AG
Maxcyte Inc.
Mirus Bio LLC
Polyplus Transfection
Promega Corporation
Roche Holding AG
Sigma-Aldrich Corporation
Thermo Fisher Scientific Inc.

Explore Full Report with TOC: https://www.imarcgroup.com/transfection-technologies-market

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.